$1M partnership to advance nanotechnology-enabled cancer research

The State University of New York (SUNY)’s College of Nanoscale Science and Engineering (CNSE; Albany, NY) and Nuclea Biotechnologies (Pittsfield, MA) have launched a $1 million research partnership to enable the development and commercialization of a high-throughput nanochip to accelerate the diagnosis and treatment of breast, colon, prostate, and other cancers.

Related: Grants worth $8 million enable study of how cancer spreads

“Driven by the vision and leadership of Governor Andrew Cuomo, New York is recognized as the leading global hub for nanotechnology education and innovation, including an expanding footprint in critical 21st century fields such as life sciences,” says Dr. Alain E. Kaloyeros, CNSE senior vice president and CEO. “This public-private partnership with Nuclea Biotechnologies expands CNSE’s cutting-edge research in the nanobioscience arena, and further illustrates its role in accelerating advanced technologies and attracting high-tech companies to New York.”
 
“This research agreement is a perfect marriage of biotechnology and nanotechnology,” says Patrick Muraca, president and CEO of Nuclea. “CNSE’s global reputation as the world leader in nanoscale engineering will lend critical expertise in developing the miniature version of our protein chip, which is an important element for us as we work toward commercialization. We’ve assembled a great team and look forward to this collaboration with CNSE.”
 
“This partnership targets important research that offers great promise for improving the quality of life for those stricken with cancer and other deadly diseases,” said Dr. James Castracane, Professor and Head of CNSE’s Nanobioscience Constellation. “We look forward to working with Nuclea Biotechnologies to develop and commercialize new sensing platforms that will enhance disease diagnosis and treatment, and ultimately, promote health care that is more efficient and cost effective.”
 
In 2005, Nuclea patented an Antibody Protein Analysis Chip to be used in their fatty acid synthase (FAS) analysis. Currently, Nuclea is able to conduct roughly 300 tests per run using the protein chip. Through this partnership with CNSE, the company expects to triple the number of tests that can be performed during each run.
 
CNSE will use its nanofabrication capabilities to help Nuclea develop a high-throughput nanochip, which would be used as a sensing platform for the analysis of biomarkers associated with cancer and other diseases. This will not only increase the number of tests per run, but will also result in smaller amounts of the biological sample necessary for testing. Concurrently, CNSE will explore methods to support the miniaturization of the protein chip.
 
Nuclea and CNSE are also discussing additional opportunities for collaboration, which may include the location of a Nuclea office and personnel at CNSE, as well as joint educational and workforce training programs.

-----

Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Subscribe now to BioOptics World magazine; it's free!

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

FDA authorizes emergency use of Zika virus molecular detection assay

The xMAP MultiFLEX Zika RNA assay combines optofluidics and digital signal processing to detect Zika virus in vitro.

Merz acquires laser tattoo removal device maker ON Light Sciences

Merz North America has acquired ON Light Sciences, which develops technologies to enhance laser-based dermatology procedures.

Shortwave-infrared device could improve ear infection diagnosis

An otoscope-like device that could improve ear infection diagnosis uses shortwave-infrared light instead of visible light.

Laser therapy extracts rare tumor that grew human hair, skin in boy's skull

About four years ago, a tumor comprised of human skin, hair, bone and cartilage was fast-growing inside a Ramsey, MN, 10-year-old youth's brain.
BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS